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Background: The therapeutic activities of Andrographis paniculata are attributed to four major active diterpenoids:
andrographolide (AP1), 14-deoxy-11,12-didehydroandrographolide (AP3), neoandrographolide (AP4), and
14-deoxyandrographolide (AP6). This study aims to quantify the four active diterpenoids in various plant organs of
A. paniculata at different growth stages in greenhouse and field experiments, with a developed HPLC-diode array
detector (HPLC-DAD) method for simultaneous determination of these diterpenoids.
Methods: Plants were grown in greenhouse and in field conditions, harvested at different growth stages, and
separated into different organs for determination of the four active diterpenoids by an HPLC-DAD method.
Results: The most abundant diterpenoid was AP6 between seedling and vegetative stages in the greenhouse
experiment (13.38 to 23.71 mg/g in 2006 and 10.67 to 24.54 mg/g in 2007). High levels of AP6 were also detected
in leaves at the transfer stage in the greenhouse experiment (36.05 ± 0.69 mg/g) and field experiment (30.59 ±
1.39 mg/g). The levels of AP6 then decreased as plants matured. The highest content of AP4 was in cotyledons
(16.65 ± 4.48 mg/g) at the transfer stage. The highest contents of AP1 were detected in leaves at seed-forming
stage in greenhouse experiment (24.72 ± 1.89 mg/g) and vegetative stage in field experiment (43.16 ± 0.92 mg/g).
Flowers of A. paniculata contained high levels of AP1 (21.42 ± 3.74 mg/g). AP3 and AP4 were at low levels in leaves
at all growth stages.
Conclusion: In A. paniculata, AP6 was at the highest level in leaves at transfer stage in both greenhouse and field
experiments. AP1 was at the highest level in leaves at vegetative stage and seed-forming stage in field and
greenhouse experiments, respectively. The contents of AP3 and AP4 in leaves were low at all growth stages.Background
Andrographis paniculata (Burm.f.) Nees, (Acanthaceae)
(known as Chuanxinlian in China) is used in Scandinavian
and Asian countries to treat the common cold, fever,
and diarrhea [1]. The aerial part of A. paniculata is
used in traditional Chinese medicine [2]. A. paniculata
is beneficial to the liver, immune system, respiratory* Correspondence: jutamaad@cri.or.th
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distribution, and reproduction in any mediumsystem, and cardiovascular system, and shows anti-in-
flammatory, antimalarial, antidiarrheal, hypoglycemic,
anti-fertility, anticancer, and anti-HIV activities [1-4].
These therapeutic activities of A. paniculata are attribu-
ted to four active diterpenoids; andrographolide (AP1),
14-deoxy-11,12-didehydroandrographolide (AP3), neoan-
drographolide (AP4), and 14-deoxyandrographolide (AP6)
[1-4], which exhibit different pharmacological activities
[2,4]. AP1 showed anti-inflammatory [5] and antican-
cer activities with stronger effects on diverse cancer
cells than AP3 and AP6 [6]. It also showed cardiopro-
tective properties [7,8]. Our previous studies indicatedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Structures of four main active diterpenoids in
Andrographis paniculata. A. andrographolide (AP1); B. 14-deoxy-
11,12-didehydroandrographolide (AP3); C. neoandrographolide (AP4);
and D. 14-deoxyandrographolide (AP6).
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anti-platelet activity than AP1 [10]. AP4 scavenged free radi-
cals [11], and showed stronger anti-inflammatory activity
than AP1 by inhibiting nitric oxide production both in vitro
and ex vivo [12]. AP4 also had antimalarial activities [13]
and hepatoprotective effects against carbon tetrachloride
[14]. AP6 is an effective antagonist of platelet activating
factor-mediated processes in bovine neutrophils via its
effects on calcium channels [15]. It also caused vasorelaxa-
tion of rat thoracic aorta [16] and relaxation of uterine
smooth muscle via selectively blocking voltage-operated
calcium channels [17].
There is a large market requirement for A. paniculata
materials, with an estimated consumption in India (aerial
part) of 250 tonnes per year [18]. A. paniculata is now
commercially cultivated to meet the high demand [19].
There have been several studies on cultivation of A. pani-
culata. Kumar et al. [20] reported that 25°C was the opti-
mal germination temperature (94.6% germination), while
there was no germination at 40°C. The growth regulators
abscisic acid and gibberellic acid also increased the AP1
content [21]. There are few reports on the contents of ac-
tive diterpenoids in A. paniculata during plant develop-
ment. Bhan et al. [22] analyzed the contents of three
diterpenoids in leaves at three harvesting dates. Prathan-
turarug et al. [23] investigated the contents of AP1 and
AP3 in field-grown A. paniculata harvested at the 60%
flowering stage. Parasher et al. [24] reported that the max-
imum AP1 content in leaves was at 120 days of maturity.
There were large variations in the contents of three
active diterpenoids (AP1, AP3, and AP4) among different
A. paniculata products in a Thai market [25]. Both the
growing region and season strongly affect production of
the diterpene lactones in this plant [1].
In this study, we developed a simple and rapid extrac-
tion method followed by simultaneous determination
of the four active diterpenoids (AP1, AP3, AP4, and
AP6) in different parts of A. paniculata. This simple
reversed-phase HPLC-diode array detector (DAD)
method was successfully applied to quantify the major
components in A. paniculata at different growth stages.
The method is sufficiently rapid, simple, sensitive, and
cost-effective to be used for quality control of raw
materials and herbal preparations [25]. DAD can be
used to identify the active compounds based on their
absorption spectra.
To our knowledge, there are no reports on the contents
of the four active diterpenoids at different growth stages
from seedling to mature stages of A. paniculata. In
addition, there are few reports on the contents of these four
active compounds in various plant organs at different
growth stages. The aim of this study was to determine
the changes in contents of the four active diterpenoids in
various plant organs of A. paniculata at different growthstages in greenhouse and field experiments at two different
cultivation times: September 2006 and January 2007.
Methods
Chemicals
Four standard diterpenoids, andrographolide (AP1, purity
99%), 14-deoxy-11,12-didehydroandrographolide (AP3, pu-
rity 96%), neoandrographolide (AP4, purity 99%), and 14-
deoxyandrographolide (AP6, purity 99%) were purified at
our Institute by the Laboratory of Pharmacology and
Laboratory of Natural Products, Chulabhorn Research
Institute (CRI), Thailand, following a method published
previously [26]. They were extracted from A. paniculata
plant materials and identified by thin-layer chromatography
(TLC), ultraviolet (UV) spectra, melting point (MP) ana-
lysis, infrared (IR) analysis, mass spectrometry (MS), and
nuclear magnetic resonance (NMR) spectroscopy. The
structures of these four active diterpenoids are shown in
Figure 1. HPLC grade methanol and acetonitrile were
obtained from Merck (Darmstadt, FR, Germany). High pu-
rity water obtained from a Milli-Q water purification sys-




A. paniculata plants were identified by Dr. Wongsatit
Chuakul and a voucher specimen was deposited at the
Pharmaceutical Botany Mahidol Herbarium, Department
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University, Bangkok, Thailand (PBM 3760). In the green-
house experiment, we studied two cultivation times: Sep-
tember 2006 and January 2007. The temperature ranged
from 24.2 to 28.5°C and the relative humidity was from 60
to 70% in the greenhouse environment. Seeds were sown
in a tray and grown in the greenhouse at CRI. Peat moss
soil (Chia Tai, Bangkok, Thailand) was used in the green-
house experiments (pH 5.5; N-P-K 12-14-24; 0.8 kg/m3).
At the seedling, first true leaf, and transfer stages, plants
were grown in the tray. At the transfer stage, plants were
transplanted into pots to grow on to the mature stages
(vegetative, 50% flowering, seed-forming, and mature-seed
stages). Plants were harvested at different growth stages
and separated into different parts (cotyledon, hypocotyl,
leaf, stem, flower, young pod including seed, pod, root,
and mature seed) depending on the growth stage (Table 1)
to quantify the four active diterpenoids. Plant materials
were washed and then dried in an oven at 35–45°C [27].
The dried plant materials were ground into a powder
using a blender (Waring Commercial, CT, USA), and kept
at room temperature until extraction and analysis.
Field experiment
Seeds were sown in the field at Ratchaburi Province,
Thailand. Plants were harvested at different growth
stages; transfer, vegetative, 50% flowering, seed-forming,
and mature-seed stages (2, 3.5, 5, 6, and 6.5 months old,
respectively) to quantify the four active diterpenoids.
Sun-dried plant materials from the field were separated
into two parts (leaves and aerial part). The dried leaves
and aerial parts were ground into powder, and kept at
room temperature until extraction and analysis.
Sample preparation
Greenhouse experiment
Dried powder (0.1 g) of A. paniculata from different
plant organs at different growth stages was accuratelyTable 1 Andrographis paniculata materials from plants at vari
two growing seasons, September 2006, and January 2007
Stages Harvesting time (days)
September 2006 January
Tray
1. Seedling 7 7
2. First true leaf 14 14
3. Transfer 39 45
Pot
4. Vegetative 108 114
5. 50% Flowering 128 141
6. Seed forming 133 149
7. Mature seed 161 206weighed (three replicates per sample, 20 plants per repli-
cate at seedling, first true leaf, and transfer stages, two
plants per replicate at other maturity stages). The plant
powder was extracted with 4 mL methanol and rotated
with a rugged rotator (Glas-Col, IN, USA) for 5 min,
and then centrifuged (Sorvall, Munich, Germany) at
1876 × g for 10 min. The supernatant was transferred
into a 10 mL volumetric flask and the crude powder was
re-extracted twice with 3 mL methanol. All extracts
were combined, the volume was adjusted, and then the
solution was filtered through a 0.45-μm nylon mem-
brane (Chrom Tech, MN, USA) before HPLC analysis.
The extraction method was modified from our previous
study [25].Field experiment
Powdered plant material (leaves or aerial part) (0.1 g) of
A. paniculata at different growth stages was accurately
weighed (three replicates per sample, 20 plants per repli-
cate at transfer stage, two plants per replicate at other
maturity stages) and then extracted as described above
for the greenhouse experiment.
HPLC-DAD
The four compounds in the methanolic extract of A.
paniculata were analyzed simultaneously by HPLC-DAD
(Agilent Technologies, Germany) on a reverse phase col-
umn (Zorbax SB-C18; 4.6 × 75 mm, 3.5 μm) connected
to a cartridge guard column (Agilent Technologies,
USA). The simple mobile phase consisted of 28% aceto-
nitrile in water with a flow rate of 1.2 mL/min. The
temperature of the column was controlled at 25°C and
the detection with the diode array detector (DAD;
Model G1315A, Agilent Technologies, Germany) at
205 nm. The injection volume was 5 μL. A standard
mixture containing AP1, AP3, AP4, and AP6 in methanol




Cotyledon, young leaf, stem, root
Cotyledon, leaf, stem, root
Leaf, stem, root
Leaf, stem, root, flower, young pod (including seed)
Leaf, stem, root, flower, young pod (including seed)
Leaf, stem, root, pod, and seed
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concentration.Statistical analysis
Data are expressed as mean ± standard deviation (SD,
n = 3). Linear regression analysis was used to compare
DAD responses and concentrations using ChemStation
software version A.10.02 (Agilent Technologies, Germany).












, which was calculated with Excel
2010 software (Microsoft, USA).Results and discussion
Method validation
Xu et al. [28] determined diterpenoids in A. paniculata
leaves by silver ion complexation in the mobile phase to
separate AP3 and AP6 with a 25-min analysis time. The
analysis time in the present study was less than 18 min.
The chromatograms in Figure 2 showed good separation
of these four active diterpenoids; a chromatogram of the
standard solution is shown, compared with samples con-
taining the highest contents of AP6 and AP1 at the trans-
fer and mature-seed stages, respectively. The calibration
curves showed good linearity in the range of 0.5 to
1000 μg/mL, and the correlation coefficients were
0.9999 for AP1, AP3, AP4, and AP6. Accuracy was deter-
mined (expressed as percentage recovery) by adding
three known amounts of standard solutions to the plant
samples, 10 replicates per concentration, and then
extracting the samples and analyzing by the HPLC
method described above. The mean recoveries of the four
active diterpenoids, AP1, AP3, AP4, and AP6, were 99.66 ±
2.22%, 98.91 ± 2.29%, 100.20 ± 1.85%, and 97.98 ± 1.90%,
respectively, indicating good accuracy of the method.
To access the precision of the method, we analyzed the
extracted sample solutions 10 times on the same day
and 10 times on 3 consecutive days. The results showed
acceptable intra- and inter-day precision, as represented
by the percent relative standard deviation (%RSD) ranging
from 0.80% to 1.02% (content) and from 0.41% to 0.66%
(retention time) for intra-day precision, and from 3.42% to
4.92% (content) and from 0.39% to 0.74% (retention time)
for inter-day precision. The limit of detection (LOD) and
limit of quantitation (LOQ) were measured based on the
signal to noise ratio of 3:1 and 10:1, respectively. The
LOD of AP1, AP3, AP4, and AP6 were 0.10, 0.25, 0.25, and
0.25 μg/mL, respectively, and the LOQ were 0.25, 0.5, 0.5,
and 0.5 μg/mL, respectively. These results showed that
our analytical method met acceptable criteria for allanalytes, and could be used for routine analysis for the
four active diterpenoids in A. paniculata.
Greenhouse experiment
There were large variations in contents of the four active
diterpenoids in different plant organs at different growth
stages. We studied the patterns of accumulation of these
four active diterpenoids in two cultivation periods: Sep-
tember 2006 (Figure 3) and January 2007 (Figure 4). The
contents of four active diterpenoids in seeds and roots
of A. paniculata were lower than limit of detection
(LOD). From the seedling to the first true leaf stages, the
highest content of AP6 was in the cotyledons (Figure 3A
and B). At the transfer stage, the highest content of AP6
was in leaves both in 2006 and 2007 (28.02 ± 0.15 and
36.05 ± 0.69 mg/g, respectively; Figures 3C and 4C). In
2006, the highest content of AP1 was in leaves at the
mature-seed stage (24.02 ± 1.18 mg/g) (Figure 3G),
whereas in 2007, the highest content of AP1 was at the
seed-forming stage (24.72 ± 1.89 mg/g) (Figure 4F).
Flowers at the 50% flowering stage also contained high
contents of AP1 in both 2006 and 2007 (21.82 ± 1.61 and
21.42 ± 3.74 mg/g, respectively) (Figures 3E and 4E). In
contrast, flowers contained low contents of the other
three active diterpenoids (≤ 0.9 mg/g). There were low
levels of AP3 in all plant organs at all growth stages
(≤ 1.4 mg/g). The highest AP3 content was at the
mature-seed stage in 2006 (1.4 ± 0.12 mg/g) and at the
vegetative stage in 2007 (0.77 ± 0.09 mg/g) (Figures 3G
and 4D). The highest content of AP4 was in cotyledons
at the transfer stage in 2006 and 2007 (3.28 ± 0.23 and
16.65 ± 4.48 mg/g, respectively) (Figures 3C and 4C).
The range of AP4 in leaves was from 0.22 mg/g to
3.72 mg/g and the content increased as plants matured.
The highest content of AP4 in leaves was at the mature-
seed stage in 2006 and 2007 (3.72 ± 1.31 and 1.88 ±
0.15 mg/g, respectively) (Figures 3G and 4G). The AP6
content in leaves was lower in 2006 (28.02 ± 0.15 mg/g)
than in 2007 (36.05 ± 0.69 mg/g), while the contents of
the other three active diterpenoids were similar in both
cultivation times. The present results also indicated that
the young plants at seedling and first true leaf stages
(harvesting time ≤ 14 days) contained high contents of
these four active diterpenoids.
Field experiment
In greenhouse and field experiments, the changes in the
contents of the four active diterpenoids at different
growth stages were similar in leaves and the aerial part
(Figures 5 and 6). However, leaves contained higher con-
tents of four active diterpenoids than the aerial part. In
the greenhouse experiment, the highest AP1 content in
leaves (24.02 ± 1.18 mg/g) was about three times higher
than that in the aerial part (8.64 ± 0.25 mg/g) at the
Figure 2 HPLC chromatograms of four diterpenoids in Andrographis paniculata. A. Four standard diterpenoids; B. Leaf sample of
Andrographis paniculata at transfer stage; and C. Leaf sample of Andrographis paniculata at mature-seed stage.
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Figure 3 Contents of four diterpenoids in various tissues of Andrographis paniculata at different growth stages (A–G) in greenhouse
experiment (September 2006). Stages were as follows: A. Seedling (7 days); B. First true leaf (14 days); C. Transfer (39 days); D. Vegetative
(108 days); E. 50% Flowering (128 days); F. Seed-forming (133 days); and G. Mature seed (161 days).
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Figure 4 (See legend on next page.)
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Figure 4 Contents of four diterpenoids in various tissues of Andrographis paniculata at different growth stages (A–G) in greenhouse
experiment (January 2007). Stages were as follows: A. Seedling (7 days); B. First true leaf (14 days); C. Transfer (45 days); D. Vegetative
(114 days); E. 50% Flowering (141 days); F. Seed-forming (149 days); and G. Mature seed (206 days).
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larly, in 2007, the highest AP1 content in leaves was four
times higher than that in the aerial part at the seed-
forming stage (24.72 ± 1.89 mg/g in leaves, 5.71 ±
0.65 mg/g in aerial part) (Figures 5B and 6B). In the field
experiment, the highest AP1 content in leaves was only
twice that in the aerial part at the vegetative stage
(43.16 ± 0.92 mg/g in leaves, 24.31 ± 1.68 mg/g in aerial
part; Figures 5C and 6C). In greenhouse (2006 and
2007) and field experiments, there was a drastic increase
of AP1 in leaves from the transfer stage (7.78 ± 0.03,
9.09 ± 0.47, and 18.43 ± 0.54 mg/g, respectively) to the
vegetative stage (19.61 ± 0.28, 15.39 ± 0.06, and 43.16 ±
0.92 mg/g, respectively; Figure 5). In the field experi-
ment, the highest content of AP1 was at the early growth
stage (vegetative stage) whereas it was at the mature-
seed and seed-forming stages in the greenhouse experi-
ment in 2006 and 2007, respectively. The highest
content of AP6 in leaves was at the transfer stage in the
field experiment (30.59 ± 1.39 mg/g) (Figure 5C) and in
the greenhouse experiment (28.02 ± 0.15 and 36.05 ±
0.69 mg/g in 2006 and 2007, respectively) (Figure 5A,
5B). In the greenhouse experiment, the AP6 content in
leaves and the aerial part increased markedly from the
first true leaf to the transfer stages and then decreased
at maturity. The pattern of AP6 accumulation in plants
was similar in the field and greenhouse experiments
(Figures 5 and 6). Moreover, there were low levels of
AP3 and AP4 in leaves and the aerial part at all growth
stages in both the greenhouse and field experiments. A.
paniculata grown in field conditions contained higher
levels of the four active diterpenoids than plants grown
in greenhouse conditions. For example, AP1 contents in
leaves at all growth stages (transfer to mature-seed
stages) were higher in field-grown plants than in
greenhouse-grown plants. Because A. paniculata was
grown under natural conditions in the field experiment,
it is difficult to control cultivation conditions that may
affect the levels of these active diterpenoids and quality
of this medicinal plant. However, these results showed
that the pattern of accumulation of the four active diter-
penoids was similar in the field and greenhouse
experiments.
To our knowledge, this is the first report to evaluate
the contents of these four active diterpenoids in different
plant organs during plant development in greenhouse
and field experiments. A. paniculata is normally har-
vested at the 50-60% flowering stage, since it was pro-
posed that plants at this stage contain the highest levelsof AP1 [22,23]. Among the active compounds extracted
from A. paniculata, AP1 is generally reported as the
major active compound [2]. Matsuda et al. [26] analyzed
whole A. paniculata plants and reported the following
diterpenoids contents on a dry weight basis: AP1 (0.6%),
AP3 (0.06%), AP4 (0.005%), and AP6 (0.02%). Sharma
et al. [29] reported that the leaves of A. paniculata con-
tained the highest content of AP1 (2.39%), similar to our
results (2.4%) in 2006 and 2007 in the greenhouse ex-
periment. However, the highest content of AP1 in our
field experiment (4.3%) was higher than that reported
previously. A new finding in our study was that the most
abundant diterpenoid was not AP1 but AP6 (in 2006 and
2007 at the seedling to vegetative stages in greenhouse
experiments, and at transfer stage in the field experi-
ment). The highest content of AP6 was found in leaves
at the transfer stage; it was four times higher than AP1
in 2006 (28.02 ± 0.15 and 7.78 ± 0.03 mg/g, respectively)
and 2007 (36.05 ± 0.69 and 9.09 ± 0.47 mg/g, respect-
ively). A. paniculata at the transfer stage with short har-
vesting time (39–45 days) contained the highest level of
AP6, which showed bioactivity as an effective vasorela-
xant [16].
Since the four active diterpenoids of A. paniculata
have different pharmacological properties, knowledge of
their different patterns of accumulation among various
plant organs and growth stages will be helpful to select
plant materials for particular purposes or disease treat-
ments. The patterns of accumulation of AP1 and AP6
were similar to those reported by Bhan et al. [22]. AP1
was continuously produced during plant growth while
AP6 content in leaves peaked at the transfer stage and
then decreased as the plants matured. In a previous re-
port, harvesting at 100 days after transplantation was
recommended to obtain plants with the highest AP1
content [22]. Prathanturarug et al. [23] reported levels
of AP1 and AP3 similar to those detected at 50% flowe-
ring stage in the present study, although the A. panicu-
lata plants were harvested at the 60% flowering stage in
their study. Recently, Parasher et al. [24] analyzed the
AP1 content in leaves at different growth stages, and
found the highest levels of AP1 in leaves at 120 days of
maturity, similar to our results (highest AP1 content was
in leaves at mature-seed and seed-forming stages). The
content of AP3 was lower than that of other diterpenoids
in these experiments. However, in our previous study,
we observed that the AP3 increased in plants and plant
products stored for a period of time [25]. Furthermore,
the stability of the amorphous form of AP1 was
Figure 5 Contents of four diterpenoids in Andrographis paniculata leaves at different growth stages. A. Greenhouse experiment
(September 2006); B. Greenhouse experiment (January 2007); C. Field experiment.
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Figure 6 Contents of four diterpenoids in Andrographis paniculata aerial part at different growth stages. A. Greenhouse experiment
(September 2006); B. Greenhouse experiment (January 2007); C. Field experiment.
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AP3 [30]. Fresh mature plants with low AP3 content and
high AP1 content should be used to treat the common
cold, rather than products that have been stored for a
period of time, which may exert cardiovascular side
effects [31]. The highest content of AP4 was at the trans-
fer stage, similar to AP6, but in cotyledons rather than
leaves. The AP4 content in leaves reported in this study
was low and slightly increased with maturity. Bhan et al.
[22] reported that the simultaneous dehydration and gly-
cosylation of AP1 formed andrographoside and AP4.
However, the AP4 content in our study was lower than
that reported in their study, which may be because of
genetic variations and/or cultivation conditions.Conclusion
In A. paniculata, AP6 was at the highest level in leaves at
transfer stage in both greenhouse and field experiments.
AP1 was at the highest level in leaves at vegetative stage
and seed-forming stage in field and greenhouse experi-
ments, respectively. The contents of AP3 and AP4 in
leaves were low at all growth stages.
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